BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9065187)

  • 1. Clinical, endocrine, and metabolic effects of two doses of gestrinone in treatment of pelvic endometriosis.
    Dawood MY; Obasiolu CW; Ramos J; Khan-Dawood FS
    Am J Obstet Gynecol; 1997 Feb; 176(2):387-94. PubMed ID: 9065187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of gestrinone in endometriosis tissue and endometrium.
    Kauppila A; Isomaa V; Rönnberg L; Vierikko P; Vihko R
    Fertil Steril; 1985 Oct; 44(4):466-70. PubMed ID: 2996949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue and endocrine responses to gestrinone and danazol in the treatment of endometriosis.
    Forbes KL; Thomas FJ
    Reprod Fertil Dev; 1993; 5(1):103-9. PubMed ID: 8234886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of gestrinone on the lipid metabolic parameters and bone mineral density in patients with endometriosis].
    Zheng P; Zhang YF; Wang JD
    Zhonghua Fu Chan Ke Za Zhi; 2005 Mar; 40(3):175-7. PubMed ID: 15840312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of a 19 nor-steroid in the treatment of endometriosis.
    Yang TS; Tsan SH; Chen CR; Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Aug; 58(2):89-96. PubMed ID: 8915110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study. Gestrinone Italian Study Group.
    Fertil Steril; 1996 Dec; 66(6):911-9. PubMed ID: 8941054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized comparative study of the metabolic effects of two regimens of gestrinone in the treatment of endometriosis.
    Worthington M; Irvine LM; Crook D; Lees B; Shaw RW; Stevenson JC
    Fertil Steril; 1993 Mar; 59(3):522-6. PubMed ID: 8458451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gestrinone in pelvic endometriosis. A one-year evaluation].
    Cervantes Villarreal E; García Zamarripa HR; Herrera Prado E; Barrón Vallejo J
    Ginecol Obstet Mex; 1995 Aug; 63():328-30. PubMed ID: 7672647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine, metabolic, and clinical effects of gestrinone in women with endometriosis.
    Venturini PL; Bertolini S; Brunenghi MC; Daga A; Fasce V; Marcenaro A; Cimato M; De Cecco L
    Fertil Steril; 1989 Oct; 52(4):589-95. PubMed ID: 2806598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Androgens and other hormones in buserelin therapy].
    Fuchs U; Zwirner M
    Geburtshilfe Frauenheilkd; 1991 Feb; 51(2):140-2. PubMed ID: 1904040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of gestrinone for the treatment of pelvic endometriosis in infertile patients.
    Pruksananonda K; Suwajanakorn S; Boonkasemsanti W; Virutamasen P
    J Med Assoc Thai; 1999 Jan; 82(1):9-14. PubMed ID: 10087732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-blind prospective trial of two doses of gestrinone in the treatment of endometriosis.
    Hornstein MD; Gleason RE; Barbieri RL
    Fertil Steril; 1990 Feb; 53(2):237-41. PubMed ID: 2404805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and endocrine effects of medical treatment of endometriosis.
    Melis GB; Mais V; Paoletti AM; Ajossa S; Guerriero S; Fioretti P
    Ann N Y Acad Sci; 1991; 622():275-82. PubMed ID: 1829594
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of gestrinone on experimental endometriosis in rabbits].
    Giu Y; Huang S; Wu X
    Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):735-7. PubMed ID: 8728919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of gestrinone after surgery in treatment of endometriosis.
    Nieto A; Tacuri C; Serra M; Keller J; Cortés-Prieto J
    Gynecol Obstet Invest; 1997; 43(3):192-4. PubMed ID: 9127134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mifepristone in the different treatments of endometriosis.
    Zhang YX
    Clin Exp Obstet Gynecol; 2016; 43(3):350-3. PubMed ID: 27328489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
    Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
    Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The gestrinone (R-2323) treatment of endometriosis].
    Hess R; Cunill E; Fuchtner C; Alam V; Romero C; Miranda C
    Rev Chil Obstet Ginecol; 1992; 57(5):334-9; discussion 339-40. PubMed ID: 1342463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The failed suppression of serum estradiol level by gonadotropin-releasing hormone agonist in a case of pelvic endometriosis.
    Tamaya T; Misao R; Nakanishi Y
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):828-9. PubMed ID: 9758002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effects of danazol and gestrinone on testosterone binding to sex hormone binding globulin in vitro and in vivo.
    Dowsett M; Forbes KL; Rose GL; Mudge JE; Jeffcoate SL
    Clin Endocrinol (Oxf); 1986 May; 24(5):555-63. PubMed ID: 3641693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.